BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences Holdings, Inc. (BFNH) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · BFNH · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
BFNH insider trading · insider activity
Source: SEC Form 4
2
Buy transactions
1
Sell transactions
2.00
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Ferguson Merle CEO | Oct 18, 2023 | Gift | 1,400,000 | — | — | 17.87M | Form 4 ↗ |
Ferguson Merle CEO | Oct 17, 2023 | Gift | 1,470,000 | — | — | 16.47M | Form 4 ↗ |
Ferguson Merle CEO | Oct 17, 2023 | Gift | 1,470,000 | — | — | 15.00M | Form 4 ↗ |
Ferguson Merle CEO | May 12, 2023 | Gift | 500,000 | — | — | 16.47M | Form 4 ↗ |
Ferguson Merle CEO | Dec 13, 2022 | Gift | 20,000 | — | — | 16.97M | Form 4 ↗ |
Ferguson Merle CEO | Sep 30, 2022 | Gift | 10,000 | — | — | 16.99M | Form 4 ↗ |
KAISER RICHARD KAISER CFO | Dec 4, 2020 | Award | 3,000,000 | $0.00 | $3.0K | 5.05M | Form 4 ↗ |
Ferguson Merle CEO | Dec 4, 2020 | Award | 11,000,000 | $0.00 | $11.0K | 15.00M | Form 4 ↗ |
KAISER RICHARD KAISER CFO | Dec 4, 2020 | Award | 3,000,000 | $0.00 | $3.0K | 5.05M | Form 4 ↗ |
KAISER RICHARD KAISER CFO/Secretary/Treasurer | Mar 31, 2020 | Award | 500,000 | $0.00 | $50 | 500.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
BioForce Nanosciences Holdings, Inc. (BFNH) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold BFNH stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
BFNH ownershipBioForce Nanosciences Holdings, Inc. (BFNH) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.